CalciMedica CBO Buys 4,500 Shares at $1.44, Shows Confidence in Biotech Firm

Eric W. Roberts, Chief Business Officer, Director, and 10% Owner of CalciMedica (CALC), reported significant insider trading activity on June 26, 2025.

Rhea-AI Filing Summary

Eric W. Roberts, Chief Business Officer, Director, and 10% Owner of CalciMedica (CALC), reported significant insider trading activity on June 26, 2025. Roberts purchased 4,500 shares of common stock at a weighted average price of $1.4406 per share through his Roth IRA account.

Following this transaction, Roberts' total beneficial ownership includes:

• 164,706 shares held directly
• 832,704 shares held indirectly through various entities including:
  • Multiple Roth IRA accounts totaling 93,378 shares
  • Valence Investments SPV entities holding 739,326 shares across three vehicles

The transaction demonstrates continued insider confidence in CalciMedica, with Roberts maintaining substantial holdings both directly and through investment vehicles. The purchase price range was between $1.43 and $1.4499 per share.

Positive

• Chief Business Officer Eric Roberts purchased 4,500 shares at $1.44 per share through his Roth IRA, demonstrating insider confidence in the company

Negative

• None.

Insider Trade Summary

Net Buyer: 4,500 shares

Net Buy 7 txns

Insider Roberts Eric W

Role CHIEF BUSINESS OFFICER

Bought 4,500 shs ($6K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,500	$1.4406	$6K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,823 shares (Indirect, By FMTC Custodian - Roth IRA FBO Eric W. Roberts); Common Stock — 164,706 shares (Direct); Common Stock — 49,894 shares (Indirect, By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA); Common Stock — 10,661 shares (Indirect, By IRA Financial Trust Company CFBO Eric W. Roberts); Common Stock — 356,989 shares (Indirect, By Valence Investments SPV IV, LLC); Common Stock — 66,228 shares (Indirect, By Valence Investments SPV V, LLC); Common Stock — 316,109 shares (Indirect, By Valence Investments SPV VI, LLC)

Footnotes (1)

1. F1. The weighted average purchase price for the transaction reported was $1.4406, and the range of prices were between $1.43 and $1.4499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CALC shares did Eric Roberts purchase on June 26, 2025?

Eric Roberts purchased 4,500 shares of CALC common stock at a weighted average price of $1.4406 per share on June 26, 2025, through his Roth IRA account.

What positions does Eric Roberts hold at CalciMedica (CALC)?

Eric Roberts holds multiple positions at CalciMedica (CALC): he serves as a Director, Chief Business Officer, and is also a 10% Owner of the company.

What is the total amount of CALC shares Eric Roberts owns directly?

Eric Roberts directly owns 164,706 shares of CalciMedica (CALC) common stock.

How many CALC shares does Eric Roberts own through Valence Investments entities?

Through Valence Investments entities, Eric Roberts indirectly owns a total of 739,326 shares: 356,989 shares through SPV IV LLC, 66,228 shares through SPV V LLC, and 316,109 shares through SPV VI LLC.

What was the price range of CALC shares purchased in the June 26, 2025 transaction?

The CALC shares were purchased at prices ranging between $1.43 and $1.4499 per share, with a weighted average purchase price of $1.4406.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/27/2025 - 07:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roberts Eric W

(Last) (First) (Middle)

C/O CALCIMEDICA, INC.

505 COAST BLVD. S. #307

(Street)

LA JOLLA CA 92037

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [ CALC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF BUSINESS OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2025		P		4,500	A	$1.4406(1)	32,823	I	By FMTC Custodian - Roth IRA FBO Eric W. Roberts
Common Stock								164,706	D
Common Stock								49,894	I	By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
Common Stock								10,661	I	By IRA Financial Trust Company CFBO Eric W. Roberts
Common Stock								356,989	I	By Valence Investments SPV IV, LLC
Common Stock								66,228	I	By Valence Investments SPV V, LLC
Common Stock								316,109	I	By Valence Investments SPV VI, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The weighted average purchase price for the transaction reported was $1.4406, and the range of prices were between $1.43 and $1.4499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

	/s/ John Dunn, Esq., Attorney-in-Fact	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.